<!DOCTYPE html>
<html>
<head>
<title>Matinas BioPharma Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)</title>
<link href="/investors/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://d1io3yog0oux5.cloudfront.net/_726ed4ae52b41f0cf9283adaf6c8a6b4/matinasbiopharma/files/theme/js/aside/ir/_js/all.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2892">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2892">Cover</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2893">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2893">Condensed Consolidated Balance Sheets</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2894">Condensed Consolidated Balance Sheets (Parenthetical)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2895">Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2896">Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2897">Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2898">Condensed  Consolidated Statements of Cash Flows (Unaudited)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2899">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2899">Description of Business</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2900">Liquidity and Plan of Operations</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2901">Summary of Significant Accounting Policies</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2902">Cash, Cash Equivalents, Restricted Cash and Marketable Securities</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2903">Fair Value Measurements</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2904">Leasehold Improvements and Equipment</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2905">Accrued Expenses and Other Liabilities</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2906">Leases</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2907">Collaboration Agreements, Licenses and Other Research and Development Agreements</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2908">Income Taxes</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2909">Stockholders??? Equity</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2910">Accumulated Other Comprehensive (Loss)/Income</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2911">Stock-based Compensation</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2912">Commitments and Contingencies</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2913">Subsequent Event</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2914">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2914">Summary of Significant Accounting Policies (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2915">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2915">Cash, Cash Equivalents, Restricted Cash and Marketable Securities (Tables)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2916">Fair Value Measurements (Tables)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2917">Leasehold Improvements and Equipment (Tables)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2918">Accrued Expenses and Other Liabilities (Tables)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2919">Leases (Tables)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2920">Stockholders??? Equity (Tables)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2921">Accumulated Other Comprehensive (Loss)/Income (Tables)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2922">Stock-based Compensation (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2923">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2923">Liquidity and Plan of Operations (Details Narrative)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2924">Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2925">Summary of Marketable Securities (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2926">Schedule of Maturities of Debt Securities Available-for-sale (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2927">Cash, Cash Equivalents, Restricted Cash and Marketable Securities (Details Narrative)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2928">Schedule of Fair Value Measurement of Assets and Liabilities (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2929">Schedule of Leasehold Improvements and Equipment (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2930">Leasehold Improvements and Equipment (Details Narrative)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2931">Schedule of Accrued Expenses (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2932">Schedule of Accrued Expenses (Details) (Parenthetical)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2933">Schedule of Maturity of Operating and Finance Leases Liabilities (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2934">Leases (Details Narrative)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2935">Collaboration Agreements, Licenses and Other Research and Development Agreements (Details Narrative)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2936">Income Taxes (Details Narrative)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2937">Summary of Shareholders Equity Warrants Outstanding (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2938">Summary of Shareholders Equity Warrants Outstanding (Details) (Parenthetical)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2939">Schedule of Anti - Diluted Securities Excluded from Computation of Earning Per Share (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2940">Schedule of Components of Accumulated Other Comprehensive (Loss)/Income (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2941">Stockholders??? Equity (Details Narrative)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2942">Schedule of Equity Compensation Plan by Arrangements (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2943">Schedule of Equity Compensation Plan by Arrangements (Details) (Parenthetical)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2944">Schedule of Recognized Stock-Based Compensation (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2945">Schedule of Stock Option Activity (Details)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2946">Stock-based Compensation (Details Narrative)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2947">Commitments and Contingencies (Details Narrative)</a></li>
                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/2948">Subsequent Event (Details Narrative)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>Schedule of Accrued Expenses (Details)</h4>
                <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>